Abstract:Background:The intestine is now known as a key metabolic organ that is involved in the development of metabolic complications in obesity and diabetes.Studies on obese and insulin resistant rodents and humans show that small intestine develops a local insulin resistance state, an altered lipid and lipoprotein metabolism, low-grade inflammation and increased paracellular permeability.Because of the complex microenvironment surrounding intestinal epithelial cells, it is not clear so far whether intestinal dyshomeostasis is primarily induced by exogenous obesity-related factors or is a response to obesity-related endogenous alterations in the host.Objectives: To assess the impact of obesity-related endogenous factors (i.e.hyperglycemia, dyslipidemia, inflammation or endocannabinoid system activation) on intestinal epithelial functions in organoids.Methods: Organoids, derived from male C57BL/ 6 mouse duodenum, were incubated 24h with the following conditions: a) inflammatory state (20 mM LPS, 100 nM TNF a, IL-1b and IFNg); b) dyslipidemia (5 mM vs. 2 mM of Palmitate:Oleate [2:1] in 1 mM BSA); c) hyperglycemia (2600 mg/L vs. 1000 mg/L); and d) endocannabinoid system activators(ACEA and Noladin).Results: Incubation of organoids with insulin (30 min, EC50=10 nM) induced a dose-response activation of Akt Ser473 phosphorylation.Insulin signaling was blunted by the induction of an inflammatory state (-50%, p<0.05) and by free fatty acid levels similar to dyslipidemia (-37%, p<0.05) while hyperglycemia only reduce insulin sensitivity at much higher glucose levels than observed in diseases [>4500 mg/L].These obesity-related endogenous factors also impact the expression of several genes related to the epithelial cell functions in the intestine.The inflammatory state increase expression of genes related to intestinal paracellular permeability ( Tjp, Ocln, Marveld2), immune and inflammatory response (Def20, Muc1, Lyz2, Tnf), lipid and lipoprotein metabolism (Mttp, Dgat1/2, Acss2, Acaca) and nutrient transport (Slc2a2/5, Slc5a1, Abcg5/8, Fabp2).Endocannabinoid system activation also led to several changes in the expression of genes related to intestinal paracellular permeability ( Tjp, Marveld2), immune and inflammatory response (Def20, Lyz2, Muc2, Tnf), lipid and lipoprotein metabolism (Mttp, Dgat1, Fabp2) and glucose homeostasis (Gip, Slc2a2/5, Slc5a1) but with divergent effects according to the ligands (ACEA vs. Noladin).Conclusion: This study demonstrates that basolateral exposure of small intestine epithelium organoids to obesity-related factors impact the ability of the cell to signal insulin and suggest the development of alterations in other key intestinal functions.Overall, this study suggests that the host metabolic states may represent an important mechanism in the development of small intestine alteration in obesity.

An Association between Decreased Small Intestinal RNA Modification and Disturbed Glucagon-like Peptide-1 Secretion under High-Fat Diet Stress

Modulation of the Gut Microbiota During High-Dose Glycerol Monolaurate-Mediated Amelioration of Obesity in Mice Fed a High-Fat Diet

Alteration of gut microbiota affects expression of adiponectin and resistin through modifying DNA methylation in high-fat diet-induced obese mice

High-fat-diet-induced gut microbiome changes in mice

Tu1206 EFFECT OF BACILLUS SUBTILIS AND ENTEROCOCCUS FAECALIS SUPERNATANT ON SERT EXPRESSION IN ENTEROCYTES AND RAT INTESTINAL TISSUES

Gut Microbiota Regulate Pancreatic Growth, Exocrine Function, and Gut Hormones

Fat and not sugar as the determining factor for gut microbiota changes, obesity, and related metabolic disorders in mice

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

The gut microbiota regulates hypothalamic inflammation and leptin sensitivity in Western diet-fed mice via a GLP-1R-dependent mechanism

Protein O-GlcNAc Modification Links Dietary and Gut Microbial Cues to the Differentiation of Enteroendocrine L Cells

Gut microbiota affects obesity susceptibility in mice through gut metabolites

A Lipidomics- and Transcriptomics-Based Analysis of the Intestine of Genetically Obese (ob/ob) and Diabetic (db/db) Mice: Links with Inflammation and Gut Microbiota

Key Pathway And Gene Alterations In The Gastric Mucosa Associated With Obesity And Obesity-Related Diabetes

Gut microbiota regulates postprandial GLP-1 response via ileal bile acid-TGR5 signaling

Gut microbiota-bile acids-glucagon like peptide-1 axis contributes the resistance to high fat diet-induced obesity in mice

Interaction between the gut microbiota and colonic enteroendocrine cells regulates host metabolism

Gut Microbiota Composition Is Associated With the Global DNA Methylation Pattern in Obesity

The Gut Microbial Regulation of Epigenetic Modification from a Metabolic Perspective

Distinct Gut Microbiota and Arachidonic Acid Metabolism in Obesity-Prone and Obesity-Resistant Mice with a High-Fat Diet

Diet-Induced Obese Mice and Leptin-Deficient Lepob/ob Mice Exhibit Increased Circulating GIP Levels Produced by Different Mechanisms

Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice